CLINICAL_TRIALS
research
· 2018-07-11
Clinical Trial Update: Modification of Rhythmic Risk Assessment by Ventricular Tachycardia Ablation
Summary
This clinical trial update describes the investigation of how ventricular tachycardia ablation may modify rhythmic risk assessment.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: University Hospital, Toulouse | Conditions: Ventricular Tachycardia | Status: UNKNOWN